Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beyond the symptom: the biology of fatigue.
Raizen DM, Mullington J, Anaclet C, Clarke G, Critchley H, Dantzer R, Davis R, Drew KL, Fessel J, Fuller PM, Gibson EM, Harrington M, Ian Lipkin W, Klerman EB, Klimas N, Komaroff AL, Koroshetz W, Krupp L, Kuppuswamy A, Lasselin J, Lewis LD, Magistretti PJ, Matos HY, Miaskowski C, Miller AH, Nath A, Nedergaard M, Opp MR, Ritchie MD, Rogulja D, Rolls A, Salamone JD, Saper C, Whittemore V, Wylie G, Younger J, Zee PC, Craig Heller H. Raizen DM, et al. Among authors: whittemore v. Sleep. 2023 Sep 8;46(9):zsad069. doi: 10.1093/sleep/zsad069. Sleep. 2023. PMID: 37224457 Free PMC article. Review.
ANA Webinars: Clinical and basic research resilience during COVID-19.
Johansen MC, Jones-London M, Koroshetz W, Masliah E, Nath A, Whittemore V, McArthur JC. Johansen MC, et al. Among authors: whittemore v. Ann Clin Transl Neurol. 2021 Jan;8(1):302-304. doi: 10.1002/acn3.51230. Epub 2020 Dec 15. Ann Clin Transl Neurol. 2021. PMID: 33321003 Free PMC article. No abstract available.
Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.
Binder DK, Boison D, Eid T, Frankel WN, Mingorance A, Smith BN, Dacks PA, Whittemore V, Poduri A; AES/NINDS Epilepsy Benchmarks Stewards. Binder DK, et al. Among authors: whittemore v. Epilepsy Curr. 2020 Jan-Feb;20(1_suppl):14S-22S. doi: 10.1177/1535759719895274. Epub 2020 Jan 15. Epilepsy Curr. 2020. PMID: 31937124 Free PMC article.
Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span.
Jones JE, Asato MR, Brown MG, Doss JL, Felton EA, Kearney JA, Talos D, Dacks PA, Whittemore V, Poduri A; NINDS/AES Benchmarks Stewards Committee. Jones JE, et al. Among authors: whittemore v. Epilepsy Curr. 2020 Jan-Feb;20(1_suppl):31S-39S. doi: 10.1177/1535759719895277. Epub 2020 Jan 23. Epilepsy Curr. 2020. PMID: 31973592 Free PMC article.
Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.
Traynelis SF, Dlugos D, Henshall D, Mefford HC, Rogawski MA, Staley KJ, Dacks PA, Whittemore V, Poduri A; National Institutes of Neurological Disorders and Stroke (NINDS)/American Epilepsy Society (AES) Epilepsy Research Benchmark Stewards. Traynelis SF, et al. Among authors: whittemore v. Epilepsy Curr. 2020 Jan-Feb;20(1_suppl):23S-30S. doi: 10.1177/1535759719895279. Epub 2020 Jan 22. Epilepsy Curr. 2020. PMID: 31965829 Free PMC article.
Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions.
Chang BS, Krishnan V, Dulla CG, Jette N, Marsh ED, Dacks PA, Whittemore V, Poduri A; NINDS/AES Epilepsy Research Benchmark Stewards Committee. Chang BS, et al. Among authors: whittemore v. Epilepsy Curr. 2020 Jan-Feb;20(1_suppl):5S-13S. doi: 10.1177/1535759719895280. Epub 2020 Jan 22. Epilepsy Curr. 2020. PMID: 31965828 Free PMC article.
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress.
Knowles JK, Helbig I, Metcalf CS, Lubbers LS, Isom LL, Demarest S, Goldberg EM, George AL Jr, Lerche H, Weckhuysen S, Whittemore V, Berkovic SF, Lowenstein DH. Knowles JK, et al. Among authors: whittemore v. Epilepsia. 2022 Oct;63(10):2461-2475. doi: 10.1111/epi.17332. Epub 2022 Jul 17. Epilepsia. 2022. PMID: 35716052 Free PMC article. Review.
Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop.
Galanopoulou AS, Löscher W, Lubbers L, O'Brien TJ, Staley K, Vezzani A, D'Ambrosio R, White HS, Sontheimer H, Wolf JA, Twyman R, Whittemore V, Wilcox KS, Klein B. Galanopoulou AS, et al. Among authors: whittemore v. Epilepsia Open. 2021 Jun;6(2):276-296. doi: 10.1002/epi4.12490. Epub 2021 May 6. Epilepsia Open. 2021. PMID: 34033232 Free PMC article.
Metabolism-based therapies for epilepsy: new directions for future cures.
Cervenka M, Pascual JM, Rho JM, Thiele E, Yellen G, Whittemore V, Hartman AL. Cervenka M, et al. Among authors: whittemore v. Ann Clin Transl Neurol. 2021 Aug;8(8):1730-1737. doi: 10.1002/acn3.51423. Epub 2021 Jul 11. Ann Clin Transl Neurol. 2021. PMID: 34247456 Free PMC article. Review.
45 results